Literature DB >> 18296120

The scent of Mycobacterium tuberculosis.

Mona Syhre1, Stephen T Chambers.   

Abstract

Worldwide, tuberculosis (TB) kills nearly 2 million people annually, yet rapid diagnosis still relies on a 100-year-old method of sputum staining for acid-fast bacilli. The advent of solid phase micro-extraction and gas chromatography/mass spectrometry makes it possible to systematically investigate whether volatile metabolites from organisms belonging to the genus Mycobacterium can be used as a rapid and highly selective alternative to the traditional diagnostic methods. We have identified four specific compounds (methyl phenylacetate, methyl p-anisate, methyl nicotinate and o-phenylanisole) from Mycobacterium tuberculosis and Mycobacterium bovis cultures grown in vitro that are distinctive volatile markers. These compounds are detectable before the visual appearance of colonies, potentially useful as the basis of a non-invasive diagnostic test for TB and have characteristic odors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296120     DOI: 10.1016/j.tube.2008.01.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  32 in total

1.  Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis.

Authors:  Arend Kolk; Michael Hoelscher; Leonard Maboko; Jutta Jung; Sjoukje Kuijper; Michael Cauchi; Conrad Bessant; Stella van Beers; Ritaban Dutta; Tim Gibson; Klaus Reither
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 2.  Towards a point-of-care test for active tuberculosis: obstacles and opportunities.

Authors:  Ruth McNerney; Peter Daley
Journal:  Nat Rev Microbiol       Date:  2011-03       Impact factor: 60.633

Review 3.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

4.  Diagnosis of tuberculosis by trained African giant pouched rats and confounding impact of pathogens and microflora of the respiratory tract.

Authors:  Georgies F Mgode; Bart J Weetjens; Thorben Nawrath; Christophe Cox; Maureen Jubitana; Robert S Machang'u; Stéphan Cohen-Bacrie; Marielle Bedotto; Michel Drancourt; Stefan Schulz; Stefan H E Kaufmann
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

Review 5.  Bacterial volatiles and diagnosis of respiratory infections.

Authors:  James E Graham
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

6.  Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.

Authors:  Nicola M Zetola; Chawangwa Modongo; Ogopotse Matsiri; Tsaone Tamuhla; Bontle Mbongwe; Keikantse Matlhagela; Enoch Sepako; Alexandro Catini; Giorgio Sirugo; Eugenio Martinelli; Roberto Paolesse; Corrado Di Natale
Journal:  J Infect       Date:  2016-12-22       Impact factor: 6.072

Review 7.  Clinical application of volatile organic compound analysis for detecting infectious diseases.

Authors:  Shneh Sethi; Ranjan Nanda; Trinad Chakraborty
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 8.  Microbial volatile compounds in health and disease conditions.

Authors:  Robin Michael Statham Thorn; John Greenman
Journal:  J Breath Res       Date:  2012-05-04       Impact factor: 3.262

9.  The volatile molecular profiles of seven Streptococcus pneumoniae serotypes.

Authors:  Theodore R Mellors; Christiaan A Rees; Flavio A Franchina; Alison Burklund; Chaya Patel; Lucy J Hathaway; Jane E Hill
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-08-29       Impact factor: 3.205

10.  Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints.

Authors:  Jiangjiang Zhu; Heather D Bean; Matthew J Wargo; Laurie W Leclair; Jane E Hill
Journal:  J Breath Res       Date:  2013-01-10       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.